Erectile dysfunction in adult males due to neurogenic, vasculogenic, psychogenic or mixed aetiology. Adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.
Erectile dysfunction of neurogenic origin secondary to spinal cord injury Initially 1.25 mcg, then 2.5 mcg as 2nd dose, followed by 5 mcg as 3rd dose. May be increased in increments of 5 mcg until optimal dose is achieved. Erectile dysfunction of vasculogenic, psychogenic or mixed aetiology Initially 2.5 mcg, then 5 mcg as 2nd dose for partial response & 7.5 mcg if no response. May be increased in increments of 5-10 mcg until optimal dose is achieved. Max therapy: Not >once daily & not >3 times wkly. Aid to aetiology diagnosis Subject w/o evidence of neurological dysfunction 20 mcg. Subject w/ evidence of neurological dysfunction Initially 5 mcg, not to exceed 10 mcg.
Discontinue use if penile angulation, cavernosal fibrosis or Peyronie's disease develops. Not for protection against STD transmission. CV or cerebrovascular risk factors, transient ischaemic attacks or unstable CV disorders; CHD, CHF or pulmonary disease. History of psychiatric disorder or addiction. May cause hypersensitivity reactions due to benzyl alcohol. Not to be co-administered w/ any other agent for erectile dysfunction. Concomitant use w/ anticoagulants eg, warfarin or heparin. Hepatic or renal impairment. Not to be used in paed.
Sign Out
